Downing Ventures, established in 2014 and headquartered in London, UK, is a venture capital firm specializing in early and growth-stage investments across various sectors, including technology, healthcare, fintech, and renewable energy. As a division of Downing LLP, the firm focuses on nurturing innovative companies with significant growth potential, providing both financial backing and strategic support to help them scale effectively.

The firm has a diverse portfolio, having invested in over 200 companies since its inception. Notable investments include Ayar Labs, Destiny Pharma, and Exonar. In 2022, Downing Ventures co-led a £4 million funding round for Qkine, a company specializing in recombinant proteins for stem cell and organoid research.